Central Laboratories White Papers & Articles

  1. AI, Virtual Participants, and the Evolving FDA Regulatory Landscape 5/27/2026

    Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.

  2. The Regulatory Governance Gap In Clinical Trial AI 5/21/2026

    Regulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.

  3. Capture Was Step One. Execution Is Step Two. 5/21/2026

    Electronic data capture transformed clinical trials, but advancing a study depends on decision workflows that interpret data, coordinate teams, and determine meaningful next actions.

  4. De-Risk Trials For Accelerated Approval And Pipeline Optimization 5/20/2026

    This e-book explores how AI-powered Historical Clinical Trial Data (HCTD) is reshaping modern trial design for oncology and rare disease research.

  5. Rethinking How We Forecast Clinical Trial Timelines 5/12/2026

    Machine learning is transforming clinical trial reporting by replacing static enrollment forecasts with dynamic, real-time milestone projections that improve predictability and oversight.

  6. State of Materiovigilance: Gaps, Technology & Outsourcing 5/12/2026

    Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.

  7. Reducing Inventory Errors In Clinical Trials 5/8/2026

    Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.

  8. Transparency In Action: The Key To Trust And Efficiency 5/8/2026

    Trust is the backbone of clinical research. Learn how you can utilize transparency and data integrity to protect participants, meet regulatory standards, and drive medical innovation.

  9. Own Your Data, Accelerate Your Cure 5/6/2026

    Move from passive donor to active innovator. Explore how patient communities are building their own research infrastructure and using AI to bypass traditional barriers to drug development.

  10. A Blueprint For Modern Obesity Research 5/6/2026

    The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.